title: Pediatric Dispersible Tablets: a Modular Approach for Rapid Prototyping.
abstract: The design of pediatric formulations is challenging. Solid dosage forms for children have to meet the needs of different ages, e.g. high number of dosing increments and strengths. A modular formulation strategy offering the possibility of rapid prototyping was applied. Different tablet compositions and the resulting tablet characteristics were investigated for dispersible tablets using customized analytical methods.
  
  
  
  Fluid bed granules were blended with extragranular components, and compressed to tablets. Disintegration behavior was studied with a Texture Analyzer and a Tensiometer.
  
  
  
  Methods for determination of disintegration time and water uptake of tablets were developed with a Texture Analyzer, and a Tensiometer, respectively. Twenty-two different tablet formulations were prepared and analyzed with respect to disintegration time, hardness, friability, and viscosity. Multivariate data analysis revealed a high impact of type and amount of viscosity enhancer on the disintegration behavior of tablets. An optimized formulation was selected with a disintegration time of 24 s.
  
  
  
  Methods providing additional information on the disintegration behavior of dispersible tablets compared to standard pharmacopoeia methods were established. Selecting the right type and level of viscosity enhancer and superdisintegrant was critical for developing pediatric tablets with a disintegration time of less than 30 s but still pleasant mouth feel.
authors.affiliation: Pharmaceutical Research and Development, F. Hoffmann-La Roche, Grenzacherstr. 124, CH-4070, Basel, Switzerland.|Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
authors.forename: Jonas
authors.initials: J
authors.lastname: Buck
authors.affiliation: Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
authors.forename: Jörg
authors.initials: J
authors.lastname: Huwyler
authors.affiliation: Pharmaceutical Research and Development, F. Hoffmann-La Roche, Grenzacherstr. 124, CH-4070, Basel, Switzerland. peter.kuehl@roche.com.
authors.forename: Peter
authors.initials: P
authors.lastname: Kühl
authors.affiliation: Pharmaceutical Research and Development, F. Hoffmann-La Roche, Grenzacherstr. 124, CH-4070, Basel, Switzerland.
authors.forename: Angela
authors.initials: A
authors.lastname: Dischinger
mesh_terms: D000284:Administration, Oral; D017332:Cetirizine / Q000008:administration & dosage / Q000737:chemistry* / Q000493:pharmacokinetics*; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D002648:Child; D004339:Drug Compounding; D006801:Humans; D013607:Tablets; D013997:Time Factors; D014783:Viscosity
chemical_list: D013607:Tablets; D017332:Cetirizine
keywords: disintegration; dispersible tablet; fluid bed; pediatric; texture analyzer